Skip to content

Effects of respiratory muscle training on pulmonary and respiratory muscle function, cardiac function and function of individuals with Parkinson's disease

Effects of inspiratory muscle training on pulmonary and respiratory muscle function, autonomic heart function and functional capacity of individuals with Parkinson's disease: a controled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6dv5kj
Enrollment
Unknown
Registered
2018-06-13
Start date
2018-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Other
E02.190.525.186
Twenty subjects will be randomly allocated into two intervention groups, one group that will receive inspiratory muscle training (IMTG) and another that will be the control group (CG). In the IMTG, th

Sponsors

Centro de Ciências Biológicas e da Saúde da Universidade Federal de São Carlos
Lead Sponsor
Centro de Ciências Biológicas e da Saúde da Universidade Federal de São Carlos
Collaborator

Eligibility

Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Individuals with idiopathic PD diagnosed previously by a neurologist physician; Aged 50-65 years; Classified in stages I to III of the modified Hoehn and Yahr Scale; Ability to walk independently.

Exclusion criteria

Exclusion criteria: History of chronic or acute non-controlled cardiovascular and respiratory diseases; Individuals with cognitive; Another neurological disease; Change of medication.

Design outcomes

Primary

MeasureTime frame
The primary outcome to be measured is the strength of the respiratory muscles, ie maximal inspiratory pressure (Pimax) and maximal expiratory pressure (Pmax) measured by a manovacuometer staggered in cmH20;The functional capacity evaluated by the Six-Minute Walk Test (6MWT) will be conducted on a track 30 meters long and 1.5 meters wide, according to the standards of the American Thoracic Society (ATS, 2002). Two tests will be performed on the same day, with a 30-minute interval between them. The largest distance traveled (SD) for statistical analysis will be considered.

Secondary

MeasureTime frame
Pulmonary function that will be assessed using spirometry or pulmonary function testing using a Vitalograph® Spirotrac 6800 spirometer with technical procedures, acceptability and reproducibility criteria performed according to the standards of the American Thoracic Society / European Respiratory Society;The evaluation of thoracic mobility will be performed using the cirtometry technique, whose purpose is to evaluate the thoracic mobility / expandability using a tape measure, staggered in centimeters (cm), which will be placed horizontally in three levels: axillary, xiphoid and abdominal. The measurements will be performed in orthostasis.;The Heart Rate Variability, evaluated by means of a Polar S810i (Polar Electro Oy, Kempele, Finland) telemetry system, will allow the acquisition of FC and iR-R data for later analysis of HRV. The recording will be performed in two conditions: 1.) At rest in the supine position, for a period of 10 minutes in spontaneous respiration; and 2.) During 4 minutes of maneuver of accentuation of respiratory sinus arrhythmia (M-ASR) where the volunteers will be oriented to maintain a respiratory cycle lasting 10 s - being 5 s of inspiration and 5 s of expiration, thus keeping the respiratory rhythm deep, between 5 to 6 cycles per min. Volunteers will monitor respiratory rate using both visual feedback, through a pointer clock, and verbal feedback provided by the evaluator.

Countries

Brazil

Contacts

Public ContactAnna Gianlorenço

Universidade Federal de São Carlos

agianlorenco@gmail.com55-16-98203-9254

Outcome results

None listed

Source: REBEC (via WHO ICTRP)